SCHEMBL13401736

SCHEMBL13401736

C=C1CC23CC[C@@H]4C(C)(C(=O)OCC)C(=O)CCC4(C)[C@@H]2CC[C@@]1(C)C3

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 13/20 0.59
BCHE P06276 3/20 0.44
F9 P00740 2/20 0.44
F12 P00748 2/20 0.44
PLAU P00749 2/20 0.44
PLAT P00750 2/20 0.44
F11 P03951 2/20 0.44
KLKB1 P03952 2/20 0.44
PRSS1 P07477 2/20 0.44
PRSS2 P07478 2/20 0.44
F7 P08709 2/20 0.44
CTRB1 P17538 2/20 0.44
PRSS3 P35030 2/20 0.44
CTRL P40313 2/20 0.44
CTRB2 Q6GPI1 2/20 0.44
CTRC Q99895 2/20 0.44
PTPN1 P18031 4/20 0.43
PTPN2 P17706 3/20 0.43
CDC25B P30305 3/20 0.43
ACHE P22303 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13401747 0.80 F10 (0.54) F10F9F12PLAUPLAT
SCHEMBL17066125 0.68 F10 (0.77) F10BCHEPTPN1PTPN2CDC25B
SCHEMBL22944436 0.68 F10 (0.62) F10BCHEF9F12PLAU
SCHEMBL13242208 0.68 F10 (0.77) F10BCHEPTPN1PTPN2CDC25B
SCHEMBL19782045 0.64 L3MBTL1 (0.58) F10BCHEPTPN1PTPN2CDC25B
SCHEMBL13401718 0.64 F10 (0.80) F10BCHEF9F12PLAU
SCHEMBL19862616 0.64 HSD11B1 (0.51) F10BCHEPTPN1PTPN2CDC25B
SCHEMBL22922212 0.63 F10 (0.78) F10BCHEPTPN1PTPN2CDC25B
SCHEMBL13436741 0.63 F10 (0.78) F10BCHEPTPN1PTPN2CDC25B
SCHEMBL13401716 0.62 F10 (0.77) F10BCHEF9F12PLAU

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100099640-A1 TISSUE DEGENERATION PROTECTION GEUNS JOANNES 2010-04-22 US disclosed
US-20100099640-A1 TISSUE DEGENERATION PROTECTION GEUNS JOANNES 2010-04-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100099640-A1 TISSUE DEGENERATION PROTECTION SORD, CASP3, TXNRD2 F10 551/4885BCHE 3941/4885F9 1886/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.